美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tocagen Inc

1.26

0.0000

成交量：- -

成交額：- -

市值：3,013.78萬

市盈率：-0.53

高：1.26

開：1.26

低：1.26

收：1.26

52周最高：6.77

52周最低：0.4220

股本：2,391.89萬

流通股本：1,828.79萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.3783

每股收益(LYR):-2.6879

淨資產收益率：-241.66%

總資產收益率：-57.82%

市淨率：14.48

市盈率(LYR):-0.47

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Tocagen Inc

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.tocagen.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Tocagen Inc. 於2007年8月在德拉瓦州註冊。該公司是一家臨床階段，癌症選擇性基因治療公司，專註於開發一流的，廣泛適用的產品候選物，旨在激活患者對自身癌症的免疫系統從內部。該公司的癌症選擇性基因治療平台建立在逆轉錄病毒複製載體或RRV上，其被設計為選擇性地將治療基因遞送到癌細胞的DNA中。該公司的基因治療方法旨在通過免疫治療的作用機制來對抗癌症，而沒有其他免疫療法常見的自身免疫毒性。公司的創立願景是“沒有人應該死於癌症”，因為它認為免疫系統可以安全地激活，以打擊病人的癌症。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TOCA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TOCA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOCA\",,,,,undefined,":{"symbol":"TOCA","market":"US","secType":"STK","nameCN":"Tocagen Inc","latestPrice":1.26,"timestamp":1592251200000,"preClose":1.26,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":18287949,"shares":23918889,"eps":-2.378269,"marketStatus":"休市中","change":0,"latestTime":"06-15 16:00:00 EDT","open":1.26,"high":1.26,"low":1.26,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.378269,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"FBRX","executeDate":"2020-06-16"},"adr":0,"adrRate":0,"listingDate":1492056000000,"exchange":"NASDAQ","adjPreClose":1.26,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOCA\",,,,,undefined,":{"symbol":"TOCA","floatShares":18287949,"roa":"-57.82%","roe":"-241.66%","lyrEps":-2.687891,"shares":23918889,"dividePrice":0,"high":1.26,"amplitude":0,"preClose":1.26,"low":1.26,"week52Low":0.422,"pbRate":"14.48","week52High":6.77,"institutionHeld":0,"latestPrice":1.26,"eps":-2.378269,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.378269,"open":1.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TOCA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-06-16","symbol":"TOCA","type":"split","dateTimestamp":1592280000000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"US","date":"2020-06-16","symbol":"TOCA","oldSymbol":"TOCA","newSymbol":"FBRX","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1592280000000},{"market":"US","date":"2020-04-23","symbol":"TOCA","fiscalQuarterEnding":"2020/03","expectedEps":-0.44,"name":null,"time":"盤後","type":"earning","dateTimestamp":1587614400000,"reportTimeType":"post","actualEps":-0.43},{"date":"2019-11-12","symbol":"TOCA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.68,"defaultRemindTime":1573592400000,"name":null,"time":"盤後","dateTimestamp":1573534800000,"actualEps":null},{"date":"2019-08-08","symbol":"TOCA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.75,"defaultRemindTime":1565294400000,"name":null,"time":"盤後","dateTimestamp":1565236800000,"actualEps":-0.81}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TOCA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TOCA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.tocagen.com","stockEarnings":[{"period":"1week","weight":-0.9333},{"period":"1month","weight":-0.9333},{"period":"3month","weight":-0.9333},{"period":"6month","weight":-0.9333},{"period":"1year","weight":-0.9333},{"period":"ytd","weight":-0.9333}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Tocagen Inc. 於2007年8月在德拉瓦州註冊。該公司是一家臨床階段，癌症選擇性基因治療公司，專註於開發一流的，廣泛適用的產品候選物，旨在激活患者對自身癌症的免疫系統 從內部。 該公司的癌症選擇性基因治療平台建立在逆轉錄病毒複製載體或RRV上，其被設計為選擇性地將治療基因遞送到癌細胞的DNA中。 該公司的基因治療方法旨在通過免疫治療的作用機制來對抗癌症，而沒有其他免疫療法常見的自身免疫毒性。 公司的創立願景是“沒有人應該死於癌症”，因為它認為免疫系統可以安全地激活，以打擊病人的癌症。","exchange":"NASDAQ","name":"Tocagen Inc","nameEN":"Tocagen Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TOCA\",market:\"US\",,,undefined,":null}}